Case Report
Behçet’s Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity?
Table 4
Results of the thrombophilia testing in our patients.
| Laboratory value | Patient A | Patient B | Patient C | Normal range |
| Antithrombin III | 92 | 162 | 76 | 70–120% | Protein C | 102 | 80 | 88 | 70–140% | Protein S | 85 | 87 | 117 | 70–140% | Anticardiolipin IgG | 6.9 | 8.5 | 9.6 | <20 GPL | Anticardiolipin IgM | 16.5 | 14 | 13.6 | <20 MPL | aB2GPI IgG | 2.2 | 4.1 | 4.3 | <20 GPL | aB2GPI IgM | 14.5 | 11.7 | 12 | <20 MPL | Lupus Anticoagulant | 1.02 | 1.07 | 1.44 | <1.20 | PCR FV Leiden | Negative | Heterozygous R506Q | Heterozygous R506Q | | PCR FII20210A | Negative | Negative | Negative | | PCR MTHFR | Homozygous C677T | Heterozygous C677T | Heterozygous C677T | | Homocysteine | 12.2 | 26 | 15 | <15 μmol/L | F VIII | 92 | 102 | 107 | 60–150% | F IX | 70 | 75 | 79 | 60–150% |
|
|